Obsidian Therapeutics Announces Completion of Mergers; $350M Concurrent PIPE

What Happened

• Obsidian Therapeutics, Inc. filed an 8‑K on August 3, 2026 announcing the closing of the previously disclosed mergers that combine Obsidian and Galera (the “Mergers”). Concurrent with the closings, Legacy Galera completed a $350.0 million Concurrent PIPE by issuing Series C Non‑Voting Convertible Preferred Stock to qualified investors pursuant to a Securities Purchase Agreement dated April 14, 2026.
• The filing also discloses a registration rights agreement, a Contingent Value Rights (CVR) plan for former Galera stockholders, 180‑day lock‑ups for certain founders/officers/directors, indemnification agreements for directors and officers, and the engagement of KPMG LLP as the Parent’s independent auditor for the year ending December 31, 2026. Audited financial statements and MD&A for Legacy Obsidian for years ended December 31, 2025 and 2024 are incorporated by reference.

Key Details

• PIPE financing: $350.0 million in Series C Non‑Voting Convertible Preferred Stock (Concurrent PIPE) issued immediately prior to the Obsidian Merger effective time.
• Registration rights: Parent must file a shelf registration under Rule 415 within 30 calendar days after closing (subject to exceptions) and use reasonable best efforts to keep it effective until resale restrictions lapse.
• CVRs: Holders of record as of July 31, 2026 receive CVRs that entitle them to (a) a pro rata share of 80% of future net proceeds from the Legacy Product over five years and (b) a pro rata share of 95% of future net proceeds from a Supportive‑Care Product divestiture over ten years; CVRs are non‑transferable (except as specified), non‑voting, not SEC‑registered and may never pay out.
• Lock‑ups and governance: Certain former Obsidian insiders (named in the filing) agreed to 180‑day transfer restrictions on shares (other than PIPE shares); indemnification agreements for directors/officers were entered on closing.
• Auditor change: Audit Committee and Board approved engagement of KPMG LLP as the Parent’s independent registered public accounting firm for the 2026 fiscal year; KPMG previously served as Legacy Obsidian’s auditor since 2024.

Why It Matters

• For investors, the Mergers create a combined company with a $350M cash infusion from the PIPE, which can fund development and operations; however, a sizable portion of potential value tied to certain legacy Galera assets is structured as contingent CVR payments that may or may not be realized. The 180‑day lock‑ups temporarily limit share sales by key insiders, while the registration rights give PIPE investors a path to resale once the shelf is effective. Audited historical financials and MD&A for Legacy Obsidian (2024–2025) are available in the filing for evaluating recent results and condition.